Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has...

Related Keywords

Ireland ,United States ,Delaware ,Dublin ,Canada ,American ,Irish ,Daniel Speciale ,Prnewswire Mallinckrodt ,Siggi Olafsson ,Joele Frank ,Wilkinson Brimmer Katcher ,Derek Belz ,Michael Freitag Aaron Palash ,Derek Naten ,Rosen Katz ,Company Specialty Generics ,Arthur Cox ,Guggenheim Securities ,Revenue Service Under Section ,Opioid Master Disbursement Trust ,Us Drug Enforcement Administration ,Us Bankruptcy Court ,District Of Delaware The Court ,Government Affairs ,Company Board Of Directors ,Company Specialty Brands ,Lipton ,Exchange Commission ,Mallinckrodt Pharmaceuticals ,Latham Watkins ,Hogan Lovells ,Initiates Voluntary Prepackaged Chapter ,Overwhelming Support ,Key Stakeholders ,Second Lien ,Operate Normally ,Serve Customers ,Deliver High Quality Therapies ,Suppliers Expected ,Restructuring Support Agreement ,Chief Executive Officer ,Specialty Generics ,Patient Advocacy Advisory Board ,Examinership Proceedings ,Specialty Brands ,Investor Relations ,Private Securities Litigation Reform Act ,Internal Revenue Service ,Internal Revenue Code ,Acthar Gel ,Enforcement Administration ,Financial Condition ,Annual Report ,Quarterly Reports ,Vice President ,Aaron Palash ,Laura Reinhard ,Wilkinson Brimmer ,Mallinckrodt Plc ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Bankruptcy ,Restructuring Amp Recapitalization ,